PRELIMINARY ASSESSMENT OF CELECOXIB AND MICRODIODE PULSE LASER TREATMENT OF DIABETIC MACULAR EDEMA
Authors:
- Emily Y. ChewECEmily Y. Chew
- Jonghyeon KimJKJonghyeon Kim
- Hanna R. ColemanHCHanna R. Coleman
- Lloyd Paul AielloLALloyd Paul Aiello
- Gary FishGFGary Fish
- Michael IpMIMichael Ip
- Julia A. HallerJHJulia A. Haller
- Maria Msc FigueroaMFMaria Msc Figueroa
- Daniel MartinDMDaniel Martin
- David CallananDCDavid Callanan
- Robert AveryRARobert Avery
- Keri Msc HammelKHKeri Msc Hammel
- 1 March 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Retina
- Vol. 30 (3) , 459-467
Abstract
Purpose: Inflammation may play an important role in the pathogenesis of diabetic macular edema, a major cause of vision loss in persons with diabetes. The purpose of this study was to evaluate combined antiinflammatory therapy and laser approaches for treating patients with diabetic macular edema. Methods: In this prospective, factorial, randomized, multicenter trial, we compared cyclo-oxygenase-2 inhibitor (celecoxib) with placebo and diode grid laser with standard Early Treatment Diabetic Retinopathy Study focal laser treatment in 86 participants with diabetic macular edema. The primary outcome is change in visual acuity of ≥15 letters from baseline, and the secondary outcomes include a 50% reduction in the retinal thickening of diabetic macular edema measured by optical coherence tomography and a 50% reduction in leakage severity on fluorescein angiography. Results: Visual acuity and retinal thickening data from >2 years of follow-up did not show evidence of differences between the medical and laser treatments. However, participants assigned to the celecoxib group were more likely to have a reduction in fluorescein leakage when compared with the placebo group (odds ratio = 3.6; P < 0.01). Conclusion: This short-term study did not find large visual function benefits of treatment with celecoxib or diode laser compared with those of standard laser treatment. A suggestive effect of celecoxib in reducing fluorescein leakage was observed.Keywords
This publication has 33 references indexed in Scilit:
- A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular EdemaOphthalmology, 2008
- Comparison of Time-Domain OCT and Fundus Photographic Assessments of Retinal Thickening in Eyes with Diabetic Macular EdemaInvestigative Ophthalmology & Visual Science, 2008
- Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled TrialsCirculation, 2008
- Subthreshold micropulse diode laser photocoagulation for clinically significant diabetic macular oedema: a three‐year follow upClinical & Experimental Ophthalmology, 2007
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionNew England Journal of Medicine, 2005
- Cyclooxygenase-2 in Human and Experimental Ischemic Proliferative RetinopathyCirculation, 2003
- Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppressionThe FASEB Journal, 2002
- Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot studyBritish Journal of Ophthalmology, 2000
- Laser Treatment of Retinal Diseases by Subthreshold Laser EffectsSeminars in Ophthalmology, 1999
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986